PhotoMedex Makes Deloitte's Technology Fast 50 Program for Greater Philadelphia

Rankings are based on percentage of fiscal year revenue growth during the five year period from 2004 - 2008.

Dennis McGrath, PhotoMedex's CEO said, "I am very pleased to note that PhotoMedex has once again placed in the prestigious Greater Philadelphia Fast 50 program. This ongoing achievement is indicative of the determination and drive embodied by the staff and Board of Directors of the Company. We are committed to the Science of Skin Health in both photoaging and disease management and are constantly striving to bring novel solutions to unmet patient needs. This level of energy and dedication drives revenues, forges relationships, delivers on promises and improves the bottom line for both our company and our clients. Most importantly, we attribute our success to the deeply rooted partnerships we've molded with worldwide physician practices that have adopted our best-in-class technologies, which have been conceived by some of the most creative luminary minds in dermatological medicine. In short, I view this achievement as a collective effort, and it is my great pleasure to take this opportunity to express my gratitude."

"With its impressive 96 percent five-year growth, PhotoMedex has earned its position among the fastest growing technology, life sciences and clean technology companies in the Greater Philadelphia region," said Michael Purcell, partner, Deloitte & Touche LLP. "Deloitte is proud to honor PhotoMedex for its achievement."

To qualify for the Technology Fast 50, companies must have base-year operating revenues of at least $50,000, and current-year operating revenues of at least $5 million. Additionally, companies must be in business for a minimum of five years, and be headquartered in the Greater Philadelphia Region. Eligibility requirements also stipulate that the Company own proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify.

PhotoMedex develops proprietary excimer laser and fiber optic systems and techniques directed toward dermatological applications, with FDA 510(k) clearances to market the XTRAC laser system for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma.

"Deloitte" is the brand under which tens of thousands of dedicated professionals in independent firms throughout the world collaborate to provide audit, consulting, financial advisory, risk management, and tax services to selected clients.

((Comments on this story may be sent to health@closeupmedia.com))

For full details on (PHMDD) PHMDD. (PHMDD) has Short Term PowerRatings at TradingMarkets. Details on (PHMDD) Short Term PowerRatings is available at This Link.